Formulation and Evaluation of Loperamide HCl fast dissolving tablets using cross treated Xanthan Gum
DOI:
https://doi.org/10.33974/sjdpp382
Abstract
Various fast dissolving drug formulations have been recently introduced into the market. This work proposes the design of novel oral fast dissolving tablets (FDT’s) of loperamide HCl with special emphasis on disintegration and dissolution studies. The main goal was augmenting the adherence to treatment of diseases which happen with diarrhea in soldiers who are exposed to diverse kinds of hostile environments. The excipients were used for this study was based on the compatibility studies. Optimized orally oral fast dissolving tablets were prepared by the direct compression method from cross xanthan gum development to the industrial scale technique. The results show that loperamide HCl FDT’s offers a rapid beginning of action and improvement in the bioavailability of poorly absorbed drugs. The manufactured FDT’s complied with the pharmacopeia guidelines regarding hardness, weight variation, thickness, friability, drug content, wetting time, percentage of water absorption, disintegration time, and in-vitro dissolution profile. Drug compatibility with excipients was checked by FTIR studies.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 K. Vinod Kumar, S. Manohar Babu, T. Srinivas, I. Syamala, B. Sirisha , SK. Shadik (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
License Terms
This is an open-access article published in the International Journal of Research in Pharmaceutical Sciences and Technology (IJRPST) by Rubatosis Publications.
It is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, reproduction, and adaptation in any medium or format, provided the original author(s) and source are appropriately credited, a link to the license is provided, and any changes made are indicated.
To view a copy of this license, visit: https://creativecommons.org/licenses/by/4.0/
For any further queries or permissions beyond the scope of this license, please contact: editor@rubatosis.org


